{'52WeekChange': None,
 'SandP52WeekChange': None,
 'address1': 'Tavor Building',
 'address2': "Sha'ar Yokneam PO Box 533",
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 31.6,
 'askSize': 1100,
 'averageDailyVolume10Day': 1006225,
 'averageVolume': 901149,
 'averageVolume10days': 1006225,
 'beta': None,
 'beta3Year': None,
 'bid': 31.5,
 'bidSize': 1000,
 'bookValue': 5.295,
 'category': None,
 'circulatingSupply': None,
 'city': 'Yokneam',
 'companyOfficers': [],
 'country': 'Israel',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 32.26,
 'dayLow': 31.09,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': -0.365,
 'enterpriseToEbitda': 15.685,
 'enterpriseToRevenue': 5.285,
 'enterpriseValue': 878683776,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 30.817429,
 'fiftyTwoWeekHigh': 58.76,
 'fiftyTwoWeekLow': 13.06,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 15690906,
 'forwardEps': 1.7,
 'forwardPE': 18.7,
 'fromCurrency': None,
 'fullTimeEmployees': 251,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.43972,
 'heldPercentInstitutions': 0.26136,
 'industry': 'Medical Devices',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/inmodemd.com',
 'longBusinessSummary': 'InMode Ltd. designs, develops, manufactures, and '
                        'markets minimally-invasive aesthetic medical products '
                        'based on its proprietary radio frequency assisted '
                        'lipolysis and deep subdermal fractional radio '
                        'frequency technologies. The company offers '
                        'minimally-invasive aesthetic medical products for '
                        'various procedures, such as liposuction with '
                        'simultaneous skin tightening, body and face '
                        'contouring, and ablative skin rejuvenation '
                        'treatments. It also designs, develops, manufactures, '
                        'and markets non-invasive medical aesthetic products '
                        'that target an array of procedures, including '
                        'permanent hair reduction, facial skin rejuvenation, '
                        'wrinkle reduction, cellulite treatment, skin '
                        'appearance and texture, and superficial benign '
                        'vascular and pigmented lesions. InMode Ltd. offers '
                        'its products directly in the United States, Canada, '
                        'the United Kingdom, Spain, Australia, and India, as '
                        'well as indirectly through distributors in 46 '
                        'countries. The company was formerly known as Invasix '
                        'Ltd. and changed its name to InMode Ltd. in November '
                        '2017. InMode Ltd. was founded in 2008 and is '
                        'headquartered in Yokneam, Israel.',
 'longName': 'InMode Ltd.',
 'market': 'us_market',
 'marketCap': 1042683392,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_100060854',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': 57324000,
 'nextFiscalYearEnd': 1640908800,
 'open': 32.13,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 2.6,
 'phone': '972 4 909 6313',
 'previousClose': 32.66,
 'priceHint': 2,
 'priceToBook': 6.003777,
 'priceToSalesTrailing12Months': 6.27178,
 'profitMargins': 0.34559,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 32.26,
 'regularMarketDayLow': 31.09,
 'regularMarketOpen': 32.13,
 'regularMarketPreviousClose': 32.66,
 'regularMarketPrice': 32.13,
 'regularMarketVolume': 602098,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 32799100,
 'sharesPercentSharesOut': 0.0548,
 'sharesShort': 1797007,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1503470,
 'shortName': 'InMode Ltd.',
 'shortPercentOfFloat': 0.1272,
 'shortRatio': 2.66,
 'startDate': None,
 'strikePrice': None,
 'symbol': 'INMD',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': 1.159,
 'trailingPE': 27.428818,
 'twoHundredDayAverage': 30.890432,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '67c11395-ae49-34b9-8b57-678b25ef31fc',
 'volume': 602098,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.inmodemd.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '2069206'}